🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The mission of SARP is to improve the understanding of severe asthma throug...
Status
Completed
Location
University of California, San Francisco
Start Date
2012-11
Trial ID
NCT01718197
The primary purpose of this study is to demonstrate the equivalence of bude...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-10-17
Trial ID
NCT06340581
Primary Objective: To evaluate the efficacy of dupilumab in children 6 to ...
Status
Completed
Location
Investigational Site Number 840031
Start Date
2017-04-21
Trial ID
NCT02948959
Treatments Being Tested
Primary Objective: To evaluate the efficacy of dupilumab, compared with pl...
Status
Completed
Location
Investigational Site Number 840022
Start Date
2015-10-15
Trial ID
NCT02528214
The purpose is to Evaluate the Efficacy, Safety, and Tolerability of 3 Diff...
Status
Completed
Location
Research Site
Start Date
2012-11
Trial ID
NCT01704495
Asthma is reported to affect between 3-14% of pregnancies making asthma med...
Status
Completed
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT01681979
Treatments Being Tested
The goal of this observational study is to determine the prevalence of remi...
Status
Recruiting
Location
Narongkorn Saiphoklang
Start Date
2026-02-01
Trial ID
NCT07351916
This study planned to assess the effect on the reduction in rate of severe ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2015-09
Trial ID
NCT02336425
The QUARTZ study is a retrospective observational cohort study using a prev...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-03
Trial ID
NCT07787117
Treatments Being Tested
Phase 3 study to evaluate the efficacy and safety of a benralizumab in pati...
Status
Completed
Location
Research Site
Start Date
2019-08-26
Trial ID
NCT04053634
Treatments Being Tested